Log in to save to my catalogue

Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate...

Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2787652487

Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis

About this item

Full title

Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis

Author / Creator

Publisher

Singapore: Codon Publications

Journal title

Allergologia et immunopathologia, 2023-01, Vol.51 (2), p.184-190

Language

English

Formats

Publication information

Publisher

Singapore: Codon Publications

More information

Scope and Contents

Contents

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that manifests in skin dryness, severe itching, and eczema, and can significantly impact a patient's quality of life. Current treatment regimens do not prevent the recurrence of the disease and are associated with adverse effects. Here, we report two cases of moderate-to-sever...

Alternative Titles

Full title

Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2787652487

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2787652487

Other Identifiers

ISSN

0301-0546

E-ISSN

1578-1267,0301-0546

DOI

10.15586/aei.v51i2.778

How to access this item